Literature DB >> 24728306

BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension.

Yu-Xuan Feng1, Dong Liu, Ming-Li Sun, Xin Jiang, Na Sun, Yi-Min Mao, Zhi-Cheng Jing.   

Abstract

INTRODUCTION: Heterozygous germline mutations of the bone morphogenetic protein type II receptor (BMPR2) gene BMPR2 are the most important predisposing factors for heritable pulmonary arterial hypertension. BMPR2 mutation was occasionally reported in pulmonary veno-occlusive disease, appetite suppressant-related pulmonary arterial hypertension (PAH), and PAH with congenital heart disease.
MATERIALS AND METHODS: In this study we identified a missense mutation (c.2296A > G) located in BMPR2 exon 12 in a patient with chronic thromboembolic pulmonary hypertension (CTEPH).
CONCLUSION: It is the first report of a BMPR2 mutation in CTEPH. Our study provides innovative insight into etiology of CTEPH. The genetic predisposing factor is an important component in the process of this CTEPH patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728306     DOI: 10.1007/s00408-014-9580-y

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  10 in total

Review 1.  Chronic thromboembolic pulmonary hypertension.

Authors:  Marius M Hoeper; Eckhard Mayer; Gérald Simonneau; Lewis J Rubin
Journal:  Circulation       Date:  2006-04-25       Impact factor: 29.690

2.  Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients.

Authors:  D Liu; Q-Q Liu; M Eyries; W-H Wu; P Yuan; R Zhang; F Soubrier; Z-C Jing
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

3.  Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.

Authors:  Xudong Yang; Lu Long; Mark Southwood; Nung Rudarakanchana; Paul D Upton; Trina K Jeffery; Carl Atkinson; Hailan Chen; Richard C Trembath; Nicholas W Morrell
Journal:  Circ Res       Date:  2005-04-21       Impact factor: 17.367

4.  BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.

Authors:  K E Roberts; J J McElroy; W P K Wong; E Yen; A Widlitz; R J Barst; J A Knowles; J H Morse
Journal:  Eur Respir J       Date:  2004-09       Impact factor: 16.671

5.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Authors:  M Riedel; V Stanek; J Widimsky; I Prerovsky
Journal:  Chest       Date:  1982-02       Impact factor: 9.410

6.  Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

Authors:  James R Runo; Cindy L Vnencak-Jones; Melissa Prince; James E Loyd; Lisa Wheeler; Ivan M Robbins; Kirk B Lane; John H Newman; Joyce Johnson; William C Nichols; John A Phillips
Journal:  Am J Respir Crit Care Med       Date:  2002-11-21       Impact factor: 21.405

7.  Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.

Authors:  Joy Cogan; Eric Austin; Lora Hedges; Bethany Womack; James West; James Loyd; Rizwan Hamid
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

8.  BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.

Authors:  M Humbert; Z Deng; G Simonneau; R J Barst; O Sitbon; M Wolf; N Cuervo; K J Moore; S E Hodge; J A Knowles; J H Morse
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

9.  Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension.

Authors:  Rajiv D Machado; Nung Rudarakanchana; Carl Atkinson; Julia A Flanagan; Rachel Harrison; Nicholas W Morrell; Richard C Trembath
Journal:  Hum Mol Genet       Date:  2003-10-28       Impact factor: 6.150

10.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

  10 in total
  4 in total

1.  A Semiconductor Chip-Based Next Generation Sequencing Procedure for the Main Pulmonary Hypertension Genes.

Authors:  Juan Gómez; Julian R Reguero; Celso Alvarez; Manuel R Junquera; Ana Arango; César Morís; Eliecer Coto
Journal:  Lung       Date:  2015-04-28       Impact factor: 2.584

Review 2.  Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.

Authors:  Sarah Medrek; Zeenat Safdar
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 3.  Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

Authors:  Rajiv D Machado; Laura Southgate; Christina A Eichstaedt; Micheala A Aldred; Eric D Austin; D Hunter Best; Wendy K Chung; Nicola Benjamin; C Gregory Elliott; Mélanie Eyries; Christine Fischer; Stefan Gräf; Katrin Hinderhofer; Marc Humbert; Steven B Keiles; James E Loyd; Nicholas W Morrell; John H Newman; Florent Soubrier; Richard C Trembath; Rebecca Rodríguez Viales; Ekkehard Grünig
Journal:  Hum Mutat       Date:  2015-10-12       Impact factor: 4.878

4.  Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.

Authors:  Christina A Eichstaedt; Jeremias Verweyen; Michael Halank; Nicola Benjamin; Christine Fischer; Eckhard Mayer; Stefan Guth; Christoph B Wiedenroth; Benjamin Egenlauf; Satenik Harutyunova; Panagiota Xanthouli; Alberto M Marra; Heinrike Wilkens; Ralf Ewert; Katrin Hinderhofer; Ekkehard Grünig
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.